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Abstract The field of drug-induced sleep endoscopy (DISE) has grown considerably over the
last 10w15 years, to now include its use in pediatric patients. In this review article, we outline
our approach to the use of this technology in Children with Airway Obstruction, most specifically in the management of children with airway obstruction and known or suspected adenotonsillar enlargement.
Copyright ª 2021 Chinese Medical Association. Publishing services by Elsevier B.V. on behalf of
KeAi Communications Co. Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).

Introduction
Obstructive sleep apnea (OSA) has a prevalence of 1%w4%
for children in the United States.1 Sequelae from pediatric
OSA can include daytime somnolence, poor school performance, behavioral and neurocognitive problems, cardiovascular complications, enuresis, growth retardation,2 and
an overall significantly reduced quality of life.3 Adenotonsillar hypertrophy has been widely recognized as the
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most significant contributor to OSA for otherwise healthy
children.2 The American Academy of Pediatrics considers
adenotonsillectomy (AT) to be first-line treatment for pediatric OSA.4 However, a recent meta-analysis reported
residual obstructive symptoms in 33.7% of children post AT.5
For patients with persistent obstructive symptoms following
AT, overnight polysomnography (PSG) is often considered
the next step in evaluation. While PSG findings are helpful
in determining the presence and severity of OSA, they do
not identify the specific location/anatomic cause of the
obstruction. Awake flexible endoscopy can be useful in
assessing for certain anatomic causes of obstruction
including lingual tonsil hypertrophy and adenoid re-growth;
however, these awake exams have not been shown to be
representative of the patient’s airway while asleep. An
article by Lee et al reported that awake flexible endoscopy
findings did not correlate to a similar scope with the patient
asleep when assessing base of tongue collapse.6 Chen et al7
demonstrated that patterns of obstruction at the level of
the lateral pharyngeal wall significantly differed in awake

https://doi.org/10.1016/j.wjorl.2021.05.002
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endoscopy compared to when the patient was asleep. The
evolution of induced sleep endoscopy has allowed providers
to assess anatomical sites causing airway obstruction
exclusively during sleep.
Sleep endoscopy was initially pioneered by Croft and
Pringle in 1989 and further developed in the 1990s.8 It was
named “drug-induced sleep endoscopy” (DISE) in 2005 by
Kezirian and Hohenhorst.2,9 The DISE technique involves an
evaluation of the upper airway using a flexible endoscope
while patients are in a pharmacologically induced sleep-like
state. The scope is passed through the nares to examine the
nasopharynx, oropharynx, larynx, and in some cases the
trachea. The procedure has been shown to be safe, with
test-retest reliability and moderate-substantial inter-rater
reliability.10 The goal of the DISE exam is to identify the
site(s) of obstruction best to target surgically for the
management of pediatric OSA. Controversy remains, however, as to how well DISE simulates physiologic sleep and,
by extension, its utility in improving OSA.11 DISE has classically been used to assess patients with persistent OSA
after AT. More recently, DISE is being used for certain surgically naı̈ve patients, further expanding the indications for
and utility of DISE. DISE and its impact on treatment of
pediatric OSA is a very active area of ongoing research.
The goal of this review article is to summarize the current literature on pediatric DISE, specifically examining the
following areas of interest: indications for DISE, anesthetic
protocols, comparison of DISE to other diagnostic modalities, DISE scoring systems, the use of DISE in surgically
naı̈ve patients, and DISE-directed surgical outcomes.

Indications for DISE
As the role of DISE continues to be studied, indications for
the procedure have expanded: ① persistent OSA after
AT,② prior to AT for patient at high risk for persistent OSA
(i.e. obesity, Down syndrome, craniofacial anomalies,
neurologic impairment),③ significant symptoms of SDB or
OSA with small tonsils and adenoids,④ occult or sleep-state
dependent laryngomalacia,⑤ evaluation for candidacy for
hypoglossal nerve stimulator procedure. The most wellstudied indication for DISE is for a child with persistent OSA
following AT. A 2016 systematic review revealed that at
least one site of obstruction was identified in 100% of
children who underwent DISE (n Z 162).2,12 Wilcox et al2 in
2017 summarized studies using DISE to identify sites of
obstruction in children with persistent OSA after AT; they
found eight studies reporting that sites were identified in
89%w100% of non-control patients. In 2017, Friedman et
al13 surveyed pediatric otolaryngologists; they found strong
agreement from responders in performing DISE for such
patients with residual OSA following AT regardless of
comorbidities. Additionally, a plethora of recent literature
has explored the role of DISE in surgically naı̈ve patients.
Studies have shown a benefit in performing DISE prior to AT
in patients who have a relatively high risk of persistent OSA
following AT, including those with obesity, Down syndrome,
craniofacial anomalies, and neurologic impairment.14e16
DISE in these patients can be useful in guiding management
should residual disease persist following AT.16 However,
opponents of this algorithm argue that airway dynamics
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change significantly following AT, such that the results of
the pre-procedure DISE are low yield as the airway dynamics will be greatly changed following AT.13 Other situations where DISE can be helpful in surgically naı̈ve patients
include children with severe symptoms of sleep-disordered
breathing (SDB) or those with OSA and small tonsils/adenoids on exam. Miller et al showed that small tonsils (1þ)
were not obstructive in most cases during DISE, and
therefore additional sites of obstruction should be considered in lieu of proceeding with AT.17 A study by Richter et
al18 highlighted the importance of identifying patients with
sleep-state dependent laryngomalacia. This disease entity
is difficult to identify on awake laryngoscopy alone.19 In a
meta-analysis by Camacho et al,20 48/62 (77.4%) of children
diagnosed with sleep-state laryngomalacia had failed prior
AT. Lastly, children who are being evaluated for hypoglossal
nerve stimulator (HNS) treatment currently require DISE
evaluation to be completed to determine candidacy for this
procedure. Caloway et al21 2019 published data from 20
patients undergoing HNS in the current ongoing pediatric
clinical trial. Circumferential collapse at the level of the
velopharynx was considered a criterion for exclusion from
the study.

Anesthetic protocols
In an ideal setting, the anesthetic for DISE should simulate a
natural sleep state while allowing for spontaneous ventilation.22 The anesthetic should not cause artificial respiratory depression, cardiovascular effects, or airway collapse
beyond what is occurring in natural sleep. It should be
repeatable, have a quick onset, be short in duration, and
not result in excessive airway secretions.23 While no
medication or combination of medications meets all these
criteria precisely, there is an extensive, ongoing effort to
find a protocol that most closely aligns with these ideals.
During the DISE procedure, most children require some
type of inhalational anesthetic agent before intravenous
(IV) line insertion. Topical anesthetic of the nasal passage is
avoided as it has been reported to potentially exaggerate
findings associated with laryngomalacia, reduce upper
airway reflexes, and impair the arousal response resulting
in increased sleep apnea severity.2,24 Also, decongestants
are to be avoided to prevent altering the accuracy of the
inferior turbinate evaluation.24
Beyond that, controversy remains as to which general
anesthetic agent should be used. While nearly all anesthetics affect upper airway muscle tone to varying degrees,
it is important to acknowledge that excessive sedation can
produce an exaggeration of collapse and create false positives in the areas causing obstruction during sleep.22,23
This highlights the importance of being mindful and intentional about the anesthetic protocol used for DISE.
Currently, multiple anesthetic protocols have been proposed (Table 1), but none have been universally accepted.
The most common anesthetic agents used in pediatric DISE
are propofol, midazolam, dexmedetomidine (DEX), ketamine, and inhalational agents (i.e. sevoflurane).23
For adults, propofol is the anesthetic most frequently
used for DISE and is titrated to a bispectral index between
50 and 75.9 For pediatric DISE, propofol has historically

Pediatric drug-induced sleep endoscopy
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Features of commonly used anesthetics for pediatric DISE.

Anesthetic agent

Features

Propofol

 Used for adult DISE
 In pediatric DISE, criticized for its potential to cause excessive
dose-dependent muscle relaxation and airway collapse
 A commonly used benzodiazepine
 Causes central apnea and peripheral muscle relaxation
 It is a preferred medication for pediatric DISE due to its minimal effect on the airway
 Studies have shown it to be less likely than propofol to cause upper airway obstruction
 It replicates only non-REM sleep
 It has been criticized for not providing adequate sedation as a single agent
 It has minimal to no effect on airway patency and
minimal effects on central respiratory drive
 Causes hypersalivation, which can make DISE more difficult
 Causes dose-dependent obstruction at various sites in the upper airway

Midazolam
DEX

Ketamine

Inhalational agents

DISE: drug-induced sleep endoscopy; DEX: dexmedetomidine; REM: rapid eye movement.

been criticized for its potential to cause excessive dosedependent muscle relaxation and airway collapse; however, in 2020, Kirkham et al16 retrospectively compared DISE
findings for children sedated with propofol versus DEX and
did not find a significant difference in the degree of upper
airway obstruction. Midazolam is a commonly used benzodiazepine for DISE but may cause both central apnea and
peripheral muscle relaxation and obstruction.23 DEX is
currently considered the preferred medication for pediatric
DISE due to its minimal effect on the airway. Unfortunately,
it replicates only nonerapid eye movement (REM) sleep and
has been criticized for not providing adequate sedation as a
single agent.25,26 Ketamine has minimal to no effect on the
airway patency and minimal effects on central respiratory
drive. However, ketamine does cause hypersalivation which
can make DISE more difficult. Lastly, inhalational agents
cause dose-dependent obstruction at various sites in the
upper airway.22
Differences in anesthetic protocols make direct comparison of DISE results difficult. For example, a head-tohead comparison of propofol and DEX showed significant
differences in upper airway scoring with DISE.27 A universally accepted anesthesia protocol is critically important
but still not agreed upon as of the date of the publication of
this manuscript.

Table 2
OSA.

Comparison of DISE to alternative diagnostic
modalities
DISE has several advantages, including the ability to obtain
a three-dimensional view of the airway and to concurrently
offer surgical intervention in the same operative setting.
Allowing for concurrent surgical intervention limits the
need for multiple anesthetics and is more convenient for
the families. One limitation of DISE is the ability to assess
only one site of obstruction at a time.2 A second disadvantage is the scope’s presence in the airway during the
exam; some argue that the scope itself can stent open the
airway during the exam, thereby changing the obstructive
pattern.28 Despite these limitations, many providers and
families feel the benefits outweigh these disadvantages and
consider pairing the diagnostic DISE with a plan for therapeutic intervention in the same operative setting.2,13
In addition to DISE, several other modalities have been
used to identify sites of obstruction for pediatric patients
with OSA (Table 2). Cine magnetic resonance imaging (MR)
is a procedure completed with the child sedated while
spontaneously ventilated. The main advantage of cine MR is
the ability to assess multiple levels of obstruction simultaneously; some feel this ability provides a better overall
assessment of the airway.2 In contrast to DISE, MR allows

Summary of advantages and disadvantages for imaging modalities assessing for sites of obstruction for patients with

Items

Advantages

Disadvantages

DISE

Can perform surgical interventions at the same
time, 3-D view
Image multiple sites simultaneously,
distinguish lingual tonsils from BOT
Evaluate for SAL
3D reconstructions, can do without sedation
Availability of plain film imaging
Availability of plain film imaging

Visualize one site at a time, scope stents the
airway, difficult for OR planning
Expensive, requires second anesthetic to
perform surgical interventions
Low yield without specific comorbidities
Radiation exposure
Unknown sensitivity and specificity
Patient is awake, sitting upright

Cine MR
MLB
CT
Cephalometrics
Lateral neck films

OR: operating room; MR: magnetic resonance imaging; BOT: base of tongue; MLB: microlaryngoscopy/bronchoscopy; SAL: synchronous
airway lesions; CT: computerized tomography.
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visualization of the obstruction without instruments in the
airway. Cine MR is also felt to be superior in its ability to
assess for glossoptosis and to distinguish lingual tonsillar
hypertrophy from base of tongue obstruction.29 The main
disadvantages of cine MR are the expense of the study and
the fact that surgical interventions would need to be
completed in a separate setting.29 Interestingly, results for
DISE and cine MR exams have not been found to specifically
correlate; Clark et al in 2017 evaluated 15 children with
OSA using DISE and cine MR and found discrepancies in the
diagnostic results in 33% of the patients.30 Most of these
diagnostic differences were attributed to the fact that the
DISE exam found additional sites of obstruction that were
not identified on MR.
Some providers perform tracheoscopy or microlaryngoscopy/bronchoscopy (MLB) at the same time as DISE
to assess for synchronous airway lesions below the level of
the glottis. A survey of pediatric otolaryngology providers in
2016 reported that 30% examine trachea/bronchi during
DISE.13 Bliss et al31 found that only 5% of patients undergoing DISE had a synchronous airway lesion (SAL) identified
with MLB and only a few of these required surgical
correction. Their study concluded that in most cases concurrent MLB with DISE is unnecessary but may be considered when there is a history of intubation, prematurity, or
other genetic, neurologic, or craniofacial comorbidities.
Additionally, they highlight that the improved optics of the
distal chip fiberoptic scopes used for DISE allow for easier
visualization of the subglottis and may be able to identify
patients who would benefit from further MLB evaluation.31
A study by Quinlan et al32 highlighted new computed
tomography (CT) technology allowing for “dynamic 3dimensional CT” imaging of the upper airway that does not
require sedation. CT may be less favorable in pediatric
patients, however, due to radiation exposure. Other reports have been published using cephalometrics and lateral
neck films to identify sites of airway obstruction.33

Table 3

Cephalometrics can use known measurements and ratios to
determine areas of narrowing and possible obstruction.
However, no known published studies identify the sensitivity and specificity of these calculated ratios.32 Lateral
neck radiographs are widely available with relatively low
cost, but the ability to identify obstruction may be limited
by the 2-dimensional result, as well as the fact that the
patient is sitting upright and is awake.

DISE scoring systems
An ideal scoring system would be standardized, validated,
and universally accepted. A standardized scoring system
would allow for objective outcome analysis after DISE between clinicians, institutions, and studies.2 Currently, there
are several published scoring systems for DISE, but no
consensus yet among providers.13 A review by Amos et al34
found that among 44 DISE studies, 21 different scoring systems were used. A study by Tejan et al35 used six different
scoring systems on the same subset of surgically naı̈ve pediatric patients undergoing DISE and concluded that all of
the scoring systems lacked standardization of anatomic sites
and rating scales. The six most common scoring systems used
for pediatric DISE are summarized in Table 3. Each system is
unique and varies by the anatomic sites, quantification, and
characterization of airway obstruction. The VOTE system has
been the most widely studied and is used in both adults and
pediatric patients.36 This system is criticized for pediatric
DISE due to its omission of the nasopharyngeal and supraglottic sites. The Chan scoring system, published in 2014,37
documents the percentage of obstruction at all sites other
than lingual tonsils, which are described as present or absent. This system is similar to VOTE but includes the nasal,
nasopharynx, and supraglottic sites. The Sleep Endoscopy
Rating Scale (SERS) and the Bachar grading system evaluate
similar sites but add an overall total score of upper airway

Commonly used scoring systems for pediatric drug-induced sleep endoscopy.

Scoring system

Details

VOTE








Chan

SERS
Bachar
Boudewyns

Fishman

LPW: lateral pharyngeal wall.













Most studied
Used in children and adults
Concise and easy to use
Evaluates: velum, oropharynx, tongue base, epiglottis
Criticized in children because it omits the nasopharynx and supraglottis
Evaluates: nose, adenoid, velum, oropharynx/LPW, tongue base,
lingual tonsils, epiglottis and supraglottis
Notes whether a jaw thrust or oral airway was required
Evaluates: nose, nasopharynx, velum, oropharynx/LPW, hypopharynx, larynx
Uses an overall score for upper airway obstruction
Evaluates: nose, nasopharynx, palate and tonsils, tongue base, hypopharynx, and larynx
Uses an overall score for upper airway obstruction
Evaluates: adenoids, tonsils, tongue base, palate, epiglottis, and supraglottis
Describes if obstruction is fixed or dynamic
Allows for generalized impression of hypotonia present or absent
Evaluates: nose, nasopharynx, lateral walls, tongue base, supraglottis
Rates the degree of obstruction at several levels
Includes the quality of exam and the level of confidence in the findings

Pediatric drug-induced sleep endoscopy
obstruction.38,39 The Boudewyns scoring system uniquely
characterizes the obstruction as fixed or dynamic and also
allows for a generalized impression as to whether hypotonia
is present or absent.40 The Fishman system evaluates the
degree of obstruction at several sites but also factors in the
quality of the exam, the confidence in the findings, and the
severity of OSA, and asks the provider to determine the
primary site of obstruction at the end of the exam.41 More
recently, Williamson et al42 published another scoring system
that evaluates obstruction at more sites than any of the six
above systems: nasal airway, adenoid, palate, tonsils and
lateral pharyngeal wall, tongue base, lingual tonsils,
vallecula, epiglottis, aryepiglottic folds, and arytenoids.
Currently, the use of multiple DISE scoring systems has
created a lack of uniformity in how DISE is reported and
studied. The need for a single universally agreed upon
scoring system for DISE is imperative to move the field of
pediatric sleep surgery forward.2

DISE for surgically naı̈ve patients
Traditionally, DISE has been used to assess the airway of
children who had persistent OSA following AT. However,
recent studies have shown utility in performing DISE on
surgically naı̈ve patients prior to AT. Gazzaz et al showed
DISE affected decision-making in surgically naı̈ve patients
with snoring and SDB in up to 35% of children. Additionally,
an alternate diagnosis or surgical target was identified by
DISE in 54% of the patients.43 Chen et al7 reported DISE
findings for patients with OSA and small tonsils and
concluded that DISE was an effective way to determine the
necessity of tonsillectomy. Miller et al reported that for
surgically naı̈ve patients with OSA and small non-obstructive tonsils, DISE was useful in identifying other sites of
obstruction. The supraglottis was the most common site of
obstruction found and supraglottoplasty was the most
common procedure performed for this patient cohort.17
Kirkham et al reported 62 surgically naı̈ve patients with OSA
who were considered high risk for having persistence after
traditional AT. These patients underwent DISE prior to any
surgical intervention. Based on the DISE findings, 42% underwent AT, while 58% underwent treatment other than AT,
including 18% who had multilevel surgery.16 This study
demonstrates the ability of DISE to change the surgical
management for pediatric patients with OSA who are surgically naı̈ve. With this knowledge, the question then becomes whether DISE should be completed on all children
prior to AT. Collu et al44 aimed to identify specific subgroups of patients for whom DISE should specifically be
considered. They concluded that DISE is not as useful for
“conventional” or classic cases. In this study, “conventional” patients were those with mild to moderate OSA and
larger tonsils; DISE changed the plan in only 4.5% of the
patients.
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in the management of pediatric OSA. A prospective study by
Hybaskova et al followed 51 pediatric patients with PSGconfirmed OSA. Based on history, physical exam, and PSG
findings, a therapeutic plan was designed prior to DISE.
Once DISE was performed, the surgical plan was changed in
60.8% of the patients based on the DISE findings.45 A recent
systematic review of pediatric patients with OSA by Saniasiaya et al8 reported that DISE findings caused a change in
the surgical plan for 30% of the patients. Similarly, Blanc et
al46 reported 31 patients with OSA/hypopnea syndrome and
found that DISE caused a change in surgical treatment of
obstruction sites in 45% of the patients.
Using DISE to guide surgical decision making is described
as DISE-directed surgery.47 Several investigators have
examined DISE-directed surgical outcomes in children using
standard objective criteria. Wootten et al assessed 26 patients retrospectively who had persistent OSA after AT.
These patients underwent DISE with DISE-directed surgical
interventions performed in the same setting. The study
reported that 92% of patients experienced subjective
improvement in symptoms as well as a decrease in mean
obstructive apnea-hypopnea index (OAHI) from 7.0  5.8
events per hour to 3.6  1.8 events per hour. Only one
patient had complete normalization of the OAHI, and the
study failed to show a statistically significant difference in
the pre- and post-operatively OAHI.47 A recent systematic
review and meta-analysis by Socarras et al demonstrated
that DISE-directed surgeries led to significant mean reductions in OAHI in children with persistent OSA following
AT. However, the authors noted that complete resolution of
the OSA is rarely observed even with DISE-directed surgery.
The study highlights that factors such as medical co-morbidities and severe baseline OSA may contribute further to
persistent disease.28 A study by He et al reported 56 pediatric patients with either persistent OSA following AT or
infant OSA. These patients underwent DISE-directed surgery and had significant improvement in both OAHI and
oxygen saturation nadir. The most commonly performed
surgical procedures were adenoidectomy (48%), supraglottoplasty (38%), tonsillectomy (27%), lingual tonsillectomy (13%), nasal surgery (11%), pharyngoplasty (7%), and
partial midline glossectomy (7%). The study found that
DISE-directed surgery had better results for children with a
lower AHI at baseline.48 Esteller et al49 showed that DISEdirected surgery led to significant improvement of OAHI in
20 otherwise healthy patients with prior AT. For surgically
naı̈ve patients, DISE-directed surgery has also been shown
to decrease OAHI. Kirkham et al5 examined 62 surgically
naı̈ve children at high risk for persistent OSA and found
significant reductions in OAHI and improvement in oxygen
nadir following DISE directed intervention. As more DISEdirected data become available in the future, the specific
role of DISE-directed surgery may become more apparent.

Future directions
The ability of DISE to change management and
DISE-directed surgical outcomes
Multiple studies have attested to the ability of DISE to
change patient management, supporting it as a useful tool

In a recent publication by Bergeron et al,50 the authors
described their institutional experience in performing DISE
in the MR induction room compared to DISE completed in
the traditional operating room. No major complications
occurred, and total time of procedure was similar. There
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was a significant cost reduction when DISE was performed in
the MR induction room. The downside remained that surgical interventions could not be incorporated in the MR
setting.

Conclusion
DISE is helpful in its ability to guide the surgical management of pediatric patients with SDB and OSA. Its utility has
been shown in managing patients with OSA who have
already had AT as well as in certain surgically naı̈ve patients. The field of pediatric sleep surgery ultimately needs
a universally agreed upon anesthetic protocol and scoring
system for DISE.

Declaration of competing interest
None.
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